|
Total population |
Total population |
Total population |
Symptomatic
infection |
Symptomatic infection |
Symptomatic infection |
|
Influenza (n=295) |
SARS-CoV2 (n=133) |
p value †
|
Influenza (n=293) |
SARS-CoV2 (n=103) |
p value
†
|
Male sex, n (%) |
155 (52.5%) |
74 (55.6%) |
0.60+ |
139 (47.4%) |
46 (44.7%) |
0.65 |
Age, median (IQR) |
3.7 (1.4-7-7) |
5.3 (1.1-11.2) |
0.093 |
5.3 (4.7) |
7.3 (5.8) |
0.002 |
Any comorbidity
Cardiovascular
Asthma
Pulmonary
Immunodeficiency
Kidney disease
Cancer
Congenital malformations
|
285 (96.6%)
56 (19%)
17 (5.8%)
42 (14.2%)
92 (31.2%)
29 (9.8%)
85 (28.8%)
88 (17.6%)
|
110 (82.7%)
17 (12.8%)
5 (3.7%)
5 (3.8%)
33 (24.8%)
12 (9%)
28 (21%)
10 (7.5%)
|
<0.001
0.13
0.48
0.001
0.21
0.86
0.09
0.007
|
283 (96.6%)
55 (18.8%)
17 (5.8%)
42 (14.3%)
92 (31.4%)
29 (9.9%)
85 (29%)
52 (17.7%)
|
85 (82.5%)
13 (12.6%)
4 (3.9%)
4 (3.9%)
25 (24.3%)
10 (9.7%)
21 (20.4%)
9 (8.7%)
|
<0.001
0.17
0.61
0.004
0.21
1
0.09
0.038
|
Nutritional status
Undernourished
Overweight/Obesity
|
88/290(30.3%)
59/290(20.3%)
|
41/131(31.3%)
22/131(16.8%)
|
0.69
..
|
87/288 (30.2%)
59/288 (20.5%)
|
19/103(28.2%)
19/103(18.4%)
|
0.77
..
|
Nosocomial acquisition |
91 (30.8%) |
25 (18.8%) |
0.010 |
89 (30.4%) |
13 (12.6%) |
<0.001 |
Symptoms at diagnosis
Asymptomatic
Fever
Cough
Pharyngodynia
Headache
Myalgia
Laboured breathing
Rhinorrhea
Vomiting
Diarrhea
|
2 (0.7%)
248 (84.1%)
222 (75.2%)
25 (8.5%)
25 (8.5%)
11 (3.7%)
134 (45.4%)
157 (53.2%)
42 (14.2%)
31 (10.5%)
|
30 (22.6%)
78 (58.6%)
31 (23.3%)
3 (2.3%)
11 (8.3%)
6 (4.5%)
35 (26.3%)
6 (4.5%)
30 (22.6%)
18 (13.5%)
|
<0.001
<0.001
<0.001
0.018
1
0.79
<0.001
<0.001
0.037
0.41
|
248 (84.6%)
222 (75.8%)
25 (8.6%)
25 (8.5%)
11 (3.7%)
134 (45.7%)
157 (53.6%)
42 (14.3%)
31 (10.6%)
|
78 (75.7%)
31 (30.1%)
3 (2.9%)
11 (10.7%)
6 (5.8%)
35 (34%)
6 (5.8%)
30 (29.1%)
18 (17.5%)
|
0.051
<0.001
0.07
0.55
0.40
0.05
<0.001
0.002
0.08
|
SaO2 <92% at hospital admission |
87 (29.5%) |
50 (37.6%) |
0.12 |
86 (29.3%) |
42 (40.8%) |
0.04 |
Hypotension |
42 (14.2%) |
11/130 (8.5%) |
0.11 |
42 (14.3%) |
10/100
(10%) |
0.31 |